Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 903576-44-3
2. Ciproxidine
3. Bf 2649
4. Pitolisant Hcl
5. Pitolisant (hydrochloride)
6. Bf 2649 Hydrochloride
7. Yv33ch63hi
8. Pitolisant Hydrochloride [usan]
9. 1-(3-(3-(4-chlorophenyl)propoxy)propyl)piperidine Hydrochloride
10. Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-, Hydrochloride
11. 903576-44-3 (hcl)
12. Wakix (tn)
13. Pitolisant Hydrochloride (usan)
14. 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine Hydrochloride
15. 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine Hydrochloride
16. Piperidine, 1-(3-(3-(4-chlorophenyl)propoxy)propyl)-, Hydrochloride
17. Bf 2.649
18. Unii-yv33ch63hi
19. Schembl4591893
20. Bf-2649 Hydrochloride
21. Chembl4164059
22. Dtxsid50238098
23. Pitolisant;ciproxidine; Bf2649
24. Amy23423
25. Bcp16427
26. Ex-a1420
27. Hy-12199b
28. Pitolisant Hydrochloride [mi]
29. S5926
30. Akos024457784
31. Cs-1501
32. Sb17036
33. Pitolisant Hydrochloride [who-dd]
34. Ac-36017
35. As-72196
36. A3727
37. Pitolisant Hydrochloride [orange Book]
38. C77058
39. D11490
40. A900088
41. Q27895485
42. 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;hydrochloride
43. 1-(3-(3-(4-chlorophenyl)propoxy)propyl)piperidine Monohydrochloride
44. Piperidine, 1-(3-(3-(4-chlorophenyl)propoxy)propyl)-, Hydrochloride (1:1)
Molecular Weight | 332.3 g/mol |
---|---|
Molecular Formula | C17H27Cl2NO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 8 |
Exact Mass | 331.1469699 g/mol |
Monoisotopic Mass | 331.1469699 g/mol |
Topological Polar Surface Area | 12.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 235 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Pitolisant Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pitolisant Hydrochloride manufacturer or Pitolisant Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pitolisant Hydrochloride manufacturer or Pitolisant Hydrochloride supplier.
PharmaCompass also assists you with knowing the Pitolisant Hydrochloride API Price utilized in the formulation of products. Pitolisant Hydrochloride API Price is not always fixed or binding as the Pitolisant Hydrochloride Price is obtained through a variety of data sources. The Pitolisant Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pitolisant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pitolisant, including repackagers and relabelers. The FDA regulates Pitolisant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pitolisant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pitolisant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pitolisant supplier is an individual or a company that provides Pitolisant active pharmaceutical ingredient (API) or Pitolisant finished formulations upon request. The Pitolisant suppliers may include Pitolisant API manufacturers, exporters, distributors and traders.
click here to find a list of Pitolisant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pitolisant DMF (Drug Master File) is a document detailing the whole manufacturing process of Pitolisant active pharmaceutical ingredient (API) in detail. Different forms of Pitolisant DMFs exist exist since differing nations have different regulations, such as Pitolisant USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pitolisant DMF submitted to regulatory agencies in the US is known as a USDMF. Pitolisant USDMF includes data on Pitolisant's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pitolisant USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pitolisant suppliers with USDMF on PharmaCompass.
A Pitolisant written confirmation (Pitolisant WC) is an official document issued by a regulatory agency to a Pitolisant manufacturer, verifying that the manufacturing facility of a Pitolisant active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pitolisant APIs or Pitolisant finished pharmaceutical products to another nation, regulatory agencies frequently require a Pitolisant WC (written confirmation) as part of the regulatory process.
click here to find a list of Pitolisant suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pitolisant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pitolisant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pitolisant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pitolisant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pitolisant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pitolisant suppliers with NDC on PharmaCompass.
Pitolisant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pitolisant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pitolisant GMP manufacturer or Pitolisant GMP API supplier for your needs.
A Pitolisant CoA (Certificate of Analysis) is a formal document that attests to Pitolisant's compliance with Pitolisant specifications and serves as a tool for batch-level quality control.
Pitolisant CoA mostly includes findings from lab analyses of a specific batch. For each Pitolisant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pitolisant may be tested according to a variety of international standards, such as European Pharmacopoeia (Pitolisant EP), Pitolisant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pitolisant USP).